| Authors: |
Smith GA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Harvard Medical School, Boston, MA, USA.; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA USA., van Belzen IAEM; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton CB10 1SA, UK., Epinette M; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA USA., Herdes E; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA USA., Mercer KL; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA USA., Butterworth CG; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton CB10 1SA, UK., Rust AG; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton CB10 1SA, UK., Flanagan AM; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton CB10 1SA, UK.; Research Department of Pathology, University College London Cancer Institute, London WC1E 6DD, UK., Jones MG; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA USA., Cortes-Ciriano I; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton CB10 1SA, UK.; Somatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK., Jacks T; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA USA. |
